NCT03095703 2024-10-24
Sirolimus and Familial Adenomatous Polyposis (FAP)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Completed
Clinical Trials
10 trialsNCT00503035 2023-02-13
Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02961374 2022-07-26
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01483144 2021-06-08
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Cancer Prevention Pharmaceuticals, Inc.
Phase 3 Completed
NCT00927485 2020-12-16
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
University of Puerto Rico
Phase NA Completed
NCT00033371 2020-09-29
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed
NCT00641147 2017-09-29
Curcumin in Treating Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed
NCT01187901 2016-06-17
FAPEST
University of Utah
Phase 2 Completed
NCT00770991 2016-02-15
Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)
The Cleveland Clinic
Phase 1 Completed
NCT00510692 2014-08-22
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
S.L.A. Pharma AG
Phase 2/3 Completed